Flora Growth (FLGC) Plummets 18% Intraday: AI Pivot Or Market Rejection?

Summary
• Flora Growth (FLGC) trades at $18.18, down 17.89% from its $22.14 previous close
• Intraday range spans $16.85–$21.24, reflecting extreme volatility
• Company rebrands as ZeroStack, pivoting to AI/blockchain after $401M funding

Flora Growth’s stock has imploded on September 30, 2025, as the market digests its radical pivot from cannabis to AI. The $401M funding led by DeFi Development Corp. and Hexstone Capital has triggered a dramatic selloff, with the stock trading near its 52-week low of $15.15. This article dissects the catalysts, technicals, and sector dynamics behind the plunge.

Strategic AI Pivot Sparks Volatility Amid Market Skepticism
Flora Growth’s 18% intraday drop follows its rebrand to ZeroStack and a $401M funding deal tied to the 0G AI blockchain project. The company’s shift from cannabis to AI has created a bifurcated market reaction: while institutional backers like DeFi Development Corp. and Hexstone Capital have committed capital, retail and algorithmic traders are selling off amid skepticism about the feasibility of decentralized AI infrastructure. The 0G token’s airdrop and Binance listing on September 22 have also introduced short-term uncertainty, with investors questioning whether the project can deliver on its 357x efficiency claims over Google’s DiLoCo benchmarks.

IT Services Sector Mixed as Flora's AI Pivot Tests Market Confidence
The IT Services sector, led by IBM (IBM) with a 1.52% intraday gain, shows mixed momentum as Flora’s AI pivot diverges from traditional tech plays. While IBM’s strength reflects institutional confidence in established AI infrastructure, Flora’s speculative blockchain-based approach has triggered a sharp selloff. The sector’s broader resilience contrasts with Flora’s volatility, highlighting the market’s risk-off stance toward unproven AI/blockchain synergies.

Technical Divergence and Volatility Playbook: ETFs and Positioning
• Bollinger Bands: Upper $30.63, Middle $24.38, Lower $18.13 (current price at $18.18, near lower band)
• MACD: 1.32 (Histogram: -1.01, bearish divergence)
• RSI: 49.76 (neutral, but oversold near 50)
• 200D MA: $5.10 (far below current price, long-term bullish)

Flora’s technicals suggest a short-term bearish bias despite long-term bullish divergence. The stock is trading near its 200-day moving average ($5.10) and Bollinger Bands’ lower boundary, indicating potential for a rebound. However, the MACD histogram’s negative divergence and RSI’s neutral stance suggest caution. With no options data available, traders should focus on key levels: $18.13 (lower band), $24.38 (middle band), and $30.63 (upper band). A break below $18.13 could trigger further selling, while a rebound above $24.38 may attract AI/blockchain bulls. The sector leader IBM’s 1.52% gain underscores institutional confidence in AI, contrasting with Flora’s speculative pivot.

Backtest Flora Growth Stock Performance
The performance of Flora Growth Corp. (FLGC) after a significant intraday plunge of -18% in 2022 can be summarized as follows:1. Revenue Growth: Flora Growth Corp. experienced a substantial increase in revenue, with a 414% rise from the third quarter of 2021 to the third quarter of 2022, reaching $10.8 million. However, this was accompanied by a net loss of $7.36 million, indicating that the company is currently unprofitable.2. Stock Performance: The stock's performance has been volatile, with a recent 14% drop following the pricing of a $5 million securities offering. This offering includes 12.5 million common shares and warrants, with the proceeds intended for capital expenditures, increased operating capacity, and general corporate purposes.3. Market Position: Flora Growth Corp. is positioned to capitalize on the global cannabis market, with a focus on cultivating and supplying medicinal-grade cannabis and related products. The company's strategic acquisitions, such as the one involving Franchise Global, are expected to enhance its product portfolio and distribution network.

Bullish Long-Term Thesis vs. Short-Term Turbulence: What's Next for Flora?
Flora’s AI pivot, while ambitious, faces immediate skepticism as reflected in its 18% intraday drop. The $401M funding and 0G token’s Binance listing offer long-term upside, but near-term volatility is likely to persist. Traders should monitor the $18.13 support level and IBM’s 1.52% gain as sector benchmarks. A sustained break above $24.38 could reignite bullish sentiment, but until then, the stock remains a high-risk, high-reward play. Watch for regulatory clarity on 0G’s AI infrastructure and institutional follow-through on the $366M in-kind token commitments.